Jonca Bull, M.D., has been appoint to a dual role as vice president of PPD Consulting, where she will serve as the head of regulatory consulting and as vice president, ophthalmology, within global product development. 
 
Dr. Bull joined the company from the U.S. FDA, where she most recently served as assistant commissioner and director of its Office of Minority Health. Prior to joining the FDA, Dr. Bull was the vice president of U.S. regulatory policy for Novartis, and formerly worked at Genentech as the director of clinical regulatory policy.
 
“Jonca possesses a wealth of experience in the regulatory arena, including with the FDA and in the pharmaceutical industry,” said Rob Dow, chief medical officer for PPD. “Her experience working closely with pharmaceutical clients, as well as health and regulatory authorities, will help enhance patient engagement for PPD clients in developing life-changing therapies.” 
 
PPD Consulting provides drug development design and planning facilities, along with experience with regulatory guidelines and the drug development process.